Musculoskeletal disorders are among the leading causes of disability worldwide, affecting millions of people with chronic pain, inflammation, and joint degeneration.
At Sanos, we are dedicated to accelerating drug development in musculoskeletal and related disorders through optimized trial designs, efficient patient recruitment, and advanced imaging technologies. Our expert CRO, NBCD, focuses on musculoskeletal and related disorders, with a deep specialization in osteoarthritis. We provide tailored clinical trial solutions that ensure high-quality data, efficient execution, and regulatory success.
With a focus on osteoarthritis, rheumatoid arthritis, and other inflammatory musculoskeletal disorders, NBCD offer deep scientific and operational expertise in musculoskeletal and related disorders clinical trials. Our approach combines cutting-edge imaging, targeted patient recruitment, and regulatory excellence to drive successful study outcomes.
At NBCD, we specialize in clinical trials for osteoarthritis, applying advanced imaging and data-driven methodologies to improve treatment outcomes. Our expertise ensures trials are designed for accuracy, efficiency, and real-world impact.
Our dedicated team has decades of experience in musculoskeletal diseases bringing deep scientific and operational expertise to every study.
NBCD has conducted numerous global studies in musculoskeletal indications, contributing to new treatment developments and regulatory approvals through high-quality clinical research.
Musculoskeletal disorders, particularly osteoarthritis, require specialized clinical trial designs to address complex joint degeneration, pain management, and patient variability. At Sanos and NBCD, we bring decades of expertise in musculoskeletal clinical research, ensuring high-quality trial execution and regulatory success across phases.
We focus on osteoarthritis, rheumatoid arthritis, and other inflammatory joint disorders, with a deep understanding of disease mechanisms that informs every stage of trial design and execution. Our expertise ensures the development of treatments that address the unique challenges of musculoskeletal diseases.
We provide comprehensive services in protocol development, endpoint selection, and regulatory submissions (FDA, EMA, global compliance), ensuring efficient trial execution and alignment with the highest scientific and regulatory standards.
With access to an extensive global network of research sites and KOLs in musculoskeletal and related disorders, we enable rapid enrollment, retention, and high-quality data collection tailored to the needs of each trial.
NBCD leverages advanced imaging techniques (X-ray, MRI), biomarkers, and AI-driven analytics to enhance patient stratification and ensure trial precision, providing more accurate insights into treatment effects.
From early-phase trials to large-scale studies, we ensure efficient project oversight, site management, data analysis, and pharmacovigilance, all aimed at driving successful regulatory submissions and patient-centered outcomes.
Delivering high-quality, science-led clinical trials
The most experienced partner in osteoarthritis research according to Global Data
Publishing to help shape musculoskeletal clinical research
Specialists in musculoskeletal clinical research, leading innovation in osteoarthritis and related disorders through precise trial execution.
“Musculoskeletal clinical research requires more than a standard CRO approach. At NBCD, we specialize in osteoarthritis and related conditions, using proprietary imaging, optimized trial designs, and decades of expertise to generate reliable, publication-ready data. Our focus means we anticipate challenges before they arise and keep trials running smoothly.”
Asger Reinstrup Bihlet, PhD, Chief Scientific Officer